Skip to Content

Investor Relations

As of August 7, 2019, Option Care and BioScrip have merged to become one national team, solely dedicated to infusion care. Option Care Health, Inc. is the largest independent...
Read More

Corporate Profile

As of August 7, 2019, Option Care and BioScrip have merged to become one national team, solely dedicated to infusion care. Option Care Health, Inc. is the largest independent home and alternate site infusion services provider in the United States. With over 6,000 teammates including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and employees.

Investor Overview

News Releases

Date Title and Summary
Toggle Summary BioScrip Acquires Intravenous Therapy Services; Establishes West Coast Platform for Specialty Infusion Operations; BioScrip Increases Existing Credit Facility to $65 Million
ELMSFORD, N.Y.--(BUSINESS WIRE)--March 2, 2006--BioScrip, Inc. (NASDAQ: BIOS) today announced that it has acquired Intravenous Therapy Services ("ITS"), a specialty infusion company located in Burbank, California. In addition, the Company announced that it has increased its existing revolving
Toggle Summary BioScrip Acquires Northland Pharmacy; Expands Community Pharmacy Model
ELMSFORD, N.Y. & MINNEAPOLIS, Oct 11, 2005 (BUSINESS WIRE) -- BioScrip, Inc. (NASDAQ:BIOS) today announced that it has acquired Northland Medical Pharmacy ("Northland"), a community-based specialty pharmacy, located in Columbus, Ohio. Henry F. Blissenbach, BioScrip's President and Chief Executive
Toggle Summary BioScrip and Home Solutions Enter Into Amended Agreement
Amendment Further Enhances Value for Shareholders Accretive Transaction Provides Substantial Operating Synergies and Deleveraging Opportunity DENVER and HAMMONTON, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of